PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Pharmacist-Led Remote Monitoring Lowers Blood Pressure, But Only in Completers

This retrospective, propensity-matched evaluation tests whether a pharmacist-led, protocol-driven remote patient monitoring (RPM) program holds up in routine care, and it shows that a large share of enrolled patients never reach the outcome analysis.
📅 Journal publication: Oct 2026 · Last updated: Oct 27, 2026
pharmacist-led careremote patient monitoringhypertensionblood pressurecollaborative practice agreementtelehealthpropensity score matchingretrospective cohortambulatory carechronic disease managementmedication titrationadherencerural health Ambulatory Care / MTM
Also in Cardiology, Clinical Practice

Background Information

Pharmacist-led telehealth program improves blood pressure control in hypertensive patients.

Hypertension is a major cardiovascular risk, especially in underserved areas. Improved management strategies are critical. Participants in the remote patient monitoring program showed greater reductions in systolic and diastolic blood pressure compared with controls. The pharmacist-led RPM program significantly lowered blood pressure, supporting pharmacist integration in hypertension management. Sustainability challenges like patient engagement and reimbursement remain. Pharmacists leading remote monitoring can improve blood pressure control more than standard care alone.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Brown C, Chandra S, Clark D 3rd

Citation: Brown C, Chandra S, Clark D 3rd Pharmacist-Led Remote Patient Monitoring for Hypertension: A Retrospective Evaluation of Blood Pressure Outcomes. Journal of the American College of Clinical Pharmacy : JACCP. 2026;9(10):e70296. doi:10.1002/jac5.70296

Article Links: PubMed · Journal / DOI

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
⚠️ Correction Notice
This article has 1 published erratum indexed on PubMed:
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Suggest a correction Request a topic
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.